Christopher J. Sweeney

机构：Australian Institute of Business, Centre for Cancer Biology, The University of Adelaide · ORCID：0000-0002-0398-6018

发表论文 831 篇 · 总被引 31371 次 · h-index 87

代表论文

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer (2025 · Nature Communications · 被引 2)
A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer (2025 · Clinical Cancer Research · 被引 2)
Development and Validation of a Computational Histology Artificial Intelligence–Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials (2026 · JCO Precision Oncology · 被引 1)
Eight-year outcomes of testosterone suppression plus enzalutamide or a nonsteroidal antiandrogen for metastatic hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304) (2026 · Annals of Oncology)
APUC-6 Genes as a Potential Prognostic and Predictive Biomarker in the CHAARTED Prostate Cancer Trial (2026 · JCO Precision Oncology)
AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial (2026 · Clinical Cancer Research)